îæ€çŽ¢
îæ€çŽ¢
î
Grace Therapeutics, Inc
GRCEîãŠã©ãããªã¹ãã«è¿œå
2.170USD
+0.010+0.46%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
35.31Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Thu, May 14
æŽæ°æå»: Thu, May 14
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Shore Pharma LLC
8.63%
Nantahala Capital Management, LLC
7.61%
SS Pharma LLC
6.97%
Rajitha Grace 2018 Irrevocable Trust
5.05%
Adar1 Capital Management LLC
4.15%
ä»ã®
67.58%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Shore Pharma LLC
8.63%
Nantahala Capital Management, LLC
7.61%
SS Pharma LLC
6.97%
Rajitha Grace 2018 Irrevocable Trust
5.05%
Adar1 Capital Management LLC
4.15%
ä»ã®
67.58%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
20.65%
Hedge Fund
12.89%
Individual Investor
6.41%
Investment Advisor
5.64%
Research Firm
3.37%
Investment Advisor/Hedge Fund
1.57%
Venture Capital
0.20%
Bank and Trust
0.02%
ä»ã®
49.26%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
43
3.68M
23.76%
-152.47K
2025Q4
40
3.74M
24.15%
+26.54K
2025Q3
40
3.65M
26.41%
-505.40K
2025Q2
46
7.78M
66.51%
+1.05M
2025Q1
48
7.92M
57.31%
+1.83M
2024Q4
47
5.99M
59.05%
-359.46K
2024Q3
42
6.02M
59.34%
-98.00K
2024Q2
44
6.05M
59.66%
+810.14K
2024Q1
42
2.77M
33.70%
+1.44M
2023Q4
43
2.08M
26.30%
+647.61K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Shore Pharma LLC
1.34M
8.63%
+147.28K
+12.40%
Jul 18, 2025
Nantahala Capital Management, LLC
1.18M
7.61%
--
--
Dec 31, 2025
SS Pharma LLC
1.08M
6.97%
+147.28K
+15.81%
Jul 18, 2025
Rajitha Grace 2018 Irrevocable Trust
781.59K
5.05%
--
--
Jul 18, 2025
Adar1 Capital Management LLC
641.99K
4.15%
+291.54K
+83.19%
Dec 31, 2025
BofA Global Research (US)
494.70K
3.2%
--
--
Dec 31, 2025
Kottayil (George)
494.70K
3.2%
--
--
Jul 18, 2025
Kavuru (Vimal)
426.32K
2.76%
--
--
Jul 18, 2025
Cerity Partners LLC
422.73K
2.73%
+422.73K
--
Dec 31, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Unusual Whales Subversive Republican Trading ETF
0%
Unusual Whales Subversive Republican Trading ETF
æ¯ç0%